Literature DB >> 21411733

A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.

Ramalingam Bethunaickan1, Celine C Berthier, Meera Ramanujam, Ranjit Sahu, Weijia Zhang, Yezou Sun, Erwin P Bottinger, Lionel Ivashkiv, Matthias Kretzler, Anne Davidson.   

Abstract

Renal infiltration with mononuclear cells is associated with poor prognosis in systemic lupus erythematosus. A renal macrophage/dendritic cell signature is associated with the onset of nephritis in NZB/W mice, and immune-modulating therapies can reverse this signature and the associated renal damage despite ongoing immune complex deposition. In nephritic NZB/W mice, renal F4/80(hi)/CD11c(int) macrophages are located throughout the interstitium, whereas F4/80(lo)/CD11c(hi) dendritic cells accumulate in perivascular lymphoid aggregates. We show here that F4/80(hi)/CD11c(int) renal macrophages have a Gr1(lo)/Ly6C(lo)/VLA4(lo)/MHCII(hi)/CD43(lo)/CD62L(lo) phenotype different from that described for inflammatory macrophages. At nephritis onset, F4/80(hi)/CD11c(int) cells upregulate cell surface CD11b, acquire cathepsin and matrix metalloproteinase activity, and accumulate large numbers of autophagocytic vacuoles; these changes reverse after the induction of remission. Latex bead labeling of peripheral blood Gr1(lo) monocytes indicates that these are the source of F4/80(hi)/CD11c(int) macrophages. CD11c(hi)/MHCII(lo) dendritic cells are found in the kidneys only after proteinuria onset, turnover rapidly, and disappear rapidly after remission induction. Gene expression profiling of the F4/80(hi)/CD11c(int) population displays increased expression of proinflammatory, regulatory, and tissue repair/degradation-associated genes at nephritis onset that reverses with remission induction. Our findings suggest that mononuclear phagocytes with an aberrant activation profile contribute to tissue damage in lupus nephritis by mediating both local inflammation and excessive tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411733      PMCID: PMC3159403          DOI: 10.4049/jimmunol.1003010

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  The chemokine system in diverse forms of macrophage activation and polarization.

Authors:  Alberto Mantovani; Antonio Sica; Silvano Sozzani; Paola Allavena; Annunciata Vecchi; Massimo Locati
Journal:  Trends Immunol       Date:  2004-12       Impact factor: 16.687

Review 2.  Macrophages and progressive tubulointerstitial disease.

Authors:  Kevin Sean Eardley; Paul Cockwell
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

3.  CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney.

Authors:  T J Soos; T N Sims; L Barisoni; K Lin; D R Littman; M L Dustin; P J Nelson
Journal:  Kidney Int       Date:  2006-06-07       Impact factor: 10.612

Review 4.  C-type lectin-like receptors on myeloid cells.

Authors:  Elwira Pyz; Andrew S J Marshall; Siamon Gordon; Gordon D Brown
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

5.  Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis.

Authors:  Thilo Krüger; Dirk Benke; Frank Eitner; Andreas Lang; Monika Wirtz; Emma E Hamilton-Williams; Daniel Engel; Bernd Giese; Gerhard Müller-Newen; Jürgen Floege; Christian Kurts
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

6.  Strain distribution pattern of susceptibility to immune-mediated nephritis.

Authors:  Chun Xie; Ruchi Sharma; Hongwei Wang; Xin J Zhou; Chandra Mohan
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

7.  Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.

Authors:  Yona Kalechman; Uzi Gafter; Talia Weinstein; Avry Chagnac; Ilya Freidkin; Ana Tobar; Michael Albeck; Benjamin Sredni
Journal:  J Biol Chem       Date:  2004-03-04       Impact factor: 5.157

8.  Similarities and differences between selective and nonselective BAFF blockade in murine SLE.

Authors:  Meera Ramanujam; Xiaobo Wang; Weiqing Huang; Zheng Liu; Lena Schiffer; Haiou Tao; Daniel Frank; Jeffrey Rice; Betty Diamond; Karl O A Yu; Steven Porcelli; Anne Davidson
Journal:  J Clin Invest       Date:  2006-02-16       Impact factor: 14.808

9.  Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13.

Authors:  Patrick Perrier; Fernando O Martinez; Massimo Locati; Giancarlo Bianchi; Manuela Nebuloni; Gianluca Vago; Flavia Bazzoni; Silvano Sozzani; Paola Allavena; Alberto Mantovani
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.

Authors:  H Ishida; T Muchamuel; S Sakaguchi; S Andrade; S Menon; M Howard
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  71 in total

Review 1.  Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states.

Authors:  Lionel B Ivashkiv
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

2.  Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.

Authors:  Celine C Berthier; Ramalingam Bethunaickan; Tania Gonzalez-Rivera; Viji Nair; Meera Ramanujam; Weijia Zhang; Erwin P Bottinger; Stephan Segerer; Maja Lindenmeyer; Clemens D Cohen; Anne Davidson; Matthias Kretzler
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

3.  Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.

Authors:  Sun-Sang J Sung; Yan Ge; Chao Dai; Hongyang Wang; Shu Man Fu; Rahul Sharma; Young S Hahn; Jing Yu; Thu H Le; Mark D Okusa; Warren K Bolton; Jessica R Lawler
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 4.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

Review 5.  Dendritic cells and macrophages in the kidney: a spectrum of good and evil.

Authors:  Natasha M Rogers; David A Ferenbach; Jeffrey S Isenberg; Angus W Thomson; Jeremy Hughes
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

6.  Identification of stage-specific genes associated with lupus nephritis and response to remission induction in (NZB × NZW)F1 and NZM2410 mice.

Authors:  Ramalingam Bethunaickan; Celine C Berthier; Weijia Zhang; Ridvan Eksi; Hong-Dong Li; Yuanfang Guan; Matthias Kretzler; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

Review 7.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

8.  Renal-infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses.

Authors:  X Liao; J Ren; A Reihl; T Pirapakaran; B Sreekumar; T E Cecere; C M Reilly; X M Luo
Journal:  Clin Exp Immunol       Date:  2017-08-18       Impact factor: 4.330

9.  CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.

Authors:  Samantha A Chalmers; Jing Wen; Justine Shum; Jessica Doerner; Leal Herlitz; Chaim Putterman
Journal:  Clin Immunol       Date:  2016-08-26       Impact factor: 3.969

Review 10.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.